Insigneo Advisory Services LLC Acquires 201 Shares of Humana Inc. (NYSE:HUM)

Insigneo Advisory Services LLC lifted its holdings in shares of Humana Inc. (NYSE:HUM) by 17.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 1,360 shares of the insurance provider’s stock after purchasing an additional 201 shares during the period. Insigneo Advisory Services LLC’s holdings in Humana were worth $345,000 as of its most recent filing with the SEC.

A number of other large investors also recently added to or reduced their stakes in HUM. Pinnacle Wealth Management Advisory Group LLC raised its stake in Humana by 3.6% in the fourth quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider’s stock worth $272,000 after buying an additional 37 shares in the last quarter. Atlas Brown Inc. raised its position in shares of Humana by 0.6% in the 4th quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider’s stock worth $1,611,000 after acquiring an additional 38 shares in the last quarter. Mather Group LLC. lifted its stake in shares of Humana by 21.0% in the 4th quarter. Mather Group LLC. now owns 236 shares of the insurance provider’s stock valued at $60,000 after purchasing an additional 41 shares during the period. Capital Advisors Ltd. LLC lifted its stake in shares of Humana by 26.1% in the 4th quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider’s stock valued at $53,000 after purchasing an additional 43 shares during the period. Finally, Retirement Planning Co of New England Inc. grew its stake in Humana by 4.7% in the fourth quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider’s stock worth $245,000 after purchasing an additional 43 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on HUM shares. Barclays upped their target price on shares of Humana from $270.00 to $322.00 and gave the stock an “equal weight” rating in a research report on Friday, April 11th. Royal Bank of Canada reissued an “outperform” rating and issued a $283.00 price target on shares of Humana in a research report on Wednesday, February 12th. StockNews.com raised Humana from a “hold” rating to a “buy” rating in a research report on Monday, April 7th. Mizuho boosted their target price on Humana from $305.00 to $316.00 and gave the stock an “outperform” rating in a report on Wednesday, April 9th. Finally, Guggenheim initiated coverage on Humana in a report on Wednesday, April 9th. They set a “buy” rating and a $326.00 price target for the company. Seventeen analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $284.90.

Humana Stock Down 7.4 %

HUM opened at $264.41 on Friday. The company has a market cap of $31.91 billion, a PE ratio of 26.57, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46. The company has a 50-day moving average price of $265.90 and a 200 day moving average price of $269.86. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM) last issued its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Sell-side analysts expect that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.34%. Humana’s dividend payout ratio is currently 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.